Member Info for Harrogate4

LDA -------"All i am expecting the abstract to be released at 5pm Eastern US time thank you in advance"

10 pm this evening UK time.

HarChris--------"wouldn't be surprised if we get that flip today what with the full abstracts from ASCO being released after hours."

You beat me to it ---I was going to say that.

Thanks for that.

Regarding the named persons on the Poster/Paper, they are:

Oncologists at major cancer centres (MD Anderson, MSKCC, The Christie, Royal Marsden/ICR, Beatson, Newcastle, Leeds, University of Washington, etc.) are principal or sub‑investigators enrolling and treating patients on the AVA6000 study.

Avacta staff (e.g., in Translational Medicine, Oncology) are sponsors’ authors responsible for the drug’s development, trial oversight, and data interpretation.

Quantitative/PK and biostatistics experts (e.g., ThinkQ2 AG, biostatistics consultants) contribute to dose‑finding, exposure–response, and statistical analysis for the trial.

Some names listed (like Renata Ferrarotto and a few others) are not on the AVA6000 author lists themselves but are tied to the same institutions and disease areas (head & neck, thoracic, solid tumors), so they sit in the broader clinical/research ecosystem around those centres rather than being clearly documented AVA6000 authors.

So , all in all, a very big participation from Avacta.

Avacta’s ASCO 2026 poster session date has not yet been released.

ASCO will publish all poster session dates and times on May 21, 2026 at 5:00 PM ET, when the full abstracts go live.

Probably, but hopefully in the reverse order

FTSE down 140 ish, Au down 100+ dollars and AVCT no significant movement.

Chinese message to Trump ---Don't mess with our plans for Taiwan.

Looking for improvements next week.

May be a good day ----for washing the hair.

Timster------"Solid analysis"

Had to go through the complete TA procedure to arrive at the conclusion though.

Nice one Pedro.

Either 90ish or 84ish ---toss of a coin stuff really.

GGP at £8.15 equivalent with over 4.5 hours of ASX to run presently. But as you say---will it hold.

The market control levers are certainly managing to minimise any potential SH "overexcitement" so far anyway today.

Maybe they might loosen up a little this afternoon, with any luck.

GGP £8.03 with over 3 hours of ASX left to run.

Saint68 --------Avacta Group shares are trading at 77.14p on the London Stock Exchange ( so the article dated 10/05/26 says)

Bit out of date isn't it ----I have it at 82.50p.

Wmsjames ------"-I actually think splitting the clinical update into two separate updates is a very good idea"

For clarity, I am presuming IFA 90's comment "Daft idea" refers to his view of my suggestion earlier to LDA, that he should e mail CC for his update that he seeks.

LDA -------"-Can I please have an update "

If I were you I would send your request for update directly to CC.

Her e mails are coughlin582@gmail.com and christina.coughlin@avacta.com.

Let us know how you get on replywise.

BV-----------President Donald Trump is set to fire FDA Commissioner Marty Makary

What's this to do with Avacta, or is this just for general interest?

AVCT SP is up and down like a tart's drawers today and hope we get some direction, maybe this afternoon.

Could bring GGP to £8+ with a favourable wind today?

MattyBoy1965------------"In any case where else would one invest the proceeds of any sale that would be a better investment than here?!"

AVCT (if you are quick)?